EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 30 filers reported holding EVOGENE LTD in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,940 | -48.5% | 8,425 | -5.6% | 0.00% | – |
| Q2 2023 | $9,585 | +70.8% | 8,925 | 0.0% | 0.00% | – |
| Q1 2023 | $5,613 | -6.4% | 8,925 | 0.0% | 0.00% | – |
| Q4 2022 | $6,000 | -14.3% | 8,925 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 8,925 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 8,925 | +20.2% | 0.00% | – |
| Q1 2022 | $10,000 | -16.7% | 7,425 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -40.0% | 7,425 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -13.0% | 7,425 | +7.6% | 0.00% | – |
| Q2 2021 | $23,000 | -34.3% | 6,900 | 0.0% | 0.00% | – |
| Q1 2021 | $35,000 | +1650.0% | 6,900 | +1633.7% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 398 | +12.4% | 0.00% | – |
| Q3 2020 | $1,000 | – | 354 | +27.3% | 0.00% | – |
| Q2 2020 | $0 | – | 278 | +1058.3% | 0.00% | – |
| Q1 2020 | $0 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
| Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
| Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
| Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
| MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
| Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
| Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |